Kala Bio KALA
NASDAQ KALA
$0.16 +0.01 (+6.67%)
At close: Nov 6, 2026 · 4:00 PM EST

Kala Bio (KALA) Other financing activities (as filed) (2017)

Updated

Kala Bio's Other financing activities (as filed) was -$139,000 in Q4 2017.

Analysis

Kala Bio (KALA) Other financing activities (as filed) (2017) Analysis & Trends

For FY2017, Other financing activities (as filed) at Kala Bio came in at -$2.25 million.

  • In earlier years, Other financing activities (as filed) was -$283,000 in FY2016 and -$1.51 million in FY2015.
  • Quarterly Other financing activities (as filed) has moved between -$1.33 million (Q3 2017) and -$19,000 (Q1 2017) over five years.
  • Per Business Quant data, KALA's Other financing activities (as filed) in the three quarters before Q4 2017 was -$1.33 million (Q3 2017), -$765,000 (Q2 2017) and -$19,000 (Q1 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Kala Bio 2.38 Mn -42.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -139,000.00
Sep 30, 2017 -1.33 Mn
Jun 30, 2017 -765,000.00
Mar 31, 2017 -19,000.00
API Access

Kala Bio Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=KALA&period=max&api_key=YOUR_API_KEY